Australia Stock Exchange release from EVE INVESTMENTS : Meluka Sales Performance Drives New Probiotic Product Range
18/10/2021 22:20
Australia Stock Exchange release from EVE INVESTMENTS EVE.AX : Meluka Sales Performance Drives New Probiotic Product Range
Recent news on Eve Health
See all newsBrief: Eve Health Appoints Ben Rohr As Chief Executive Officer
Australia's EVE Health slips on discounted placement
Brief: Eve Health Group Seeks Trading Halt For Capital Raising Consideration And Planning
Brief: Eve Health Signs Telehealth Services Agreement With Hubmed
Brief: Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share